Development of Dengue type-2 virus replicons expressing GFP reporter gene in study of viral RNA replication

Virus Research

Volumn 163, Issue 2, 2012, Pages 552-562

  Leardkamolkarn, Vijittra ^a,c   Sirigulpanit, Wipawan ^a   Chotiwan, Nunya ^a   Kumkate, Supeecha ^a   Huang, Claire Y H ^b  

^a Mahidol University ^*  (Thailand)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

5' NCR mutation; Dengue virus type 2; DENV GFP plasmid; Subgenomic replicons

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS 2; GENE CONSTRUCT; GENE DELETION; GENETIC TRANSFECTION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REPLICON; RNA REPLICATION; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS MORPHOLOGY; VIRUS MUTATION; VIRUS REPLICATION; VIRUS VIRULENCE;

DENGUE VIRUS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; RECOMBINATION, GENETIC; REPLICON; RNA, VIRAL; STAINING AND LABELING; VIROLOGY; VIRUS REPLICATION;

DENGUE VIRUS; DENGUE VIRUS TYPE 2; FLAVIVIRUS;

EID: 84856556194     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.12.007     Document Type: Article

References (45)

1. Akrigg A., Wilkinson G.W., Oram J.D. The structure of the major immediate early gene of human cytomegalovirus strain AD169. Virus Res. 1985, 2:107-121.
2. Ali N., Siddiqui A. Interaction of polypyrimidine tract-binding protein with the 5' noncoding region of the hepatitis C virus RNA genome and its functional requirementin internal initiation of translation. J. Virol. 1995, 69:6367-6375.
3. Alvarez D.E., De Lella Ezcurra A.L., Fucito S., Gamarnik A.V. Role of RNA structures present at the 3'UTR of dengue virus on translation. RNA synthesis, and viral replication. Virology 2005, 339:200-212.
4. Amberg S.M., Nestorowicz A., McCourt D.W., Rice C.M. NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies. J. Virol. 1994, 68:3794-3802.
5. Amberg S.M., Rice C.M. Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing. J. Virol. 1999, 73:8083-8094.
6. Bonaldo M.C., Mello S.M., Trindade G.F., Rangel A.A., Duarte A.S., Oliveira P.J., Freire M.S., Kubelka C.F., Galler R. Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes. Virol. J. 2007, 4:115. doi: 1.10.1186/1743-422X-4-115.
7. Butrapet S., Huang C.Y., Pierro D.J., Bhamarapravati N., Gubler D.J., Kinney R.M. Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3. J. Virol. 2000, 74:3011-3019.
8. Cahour A., Pletnev A., Vazielle-Falcoz M., Rosen L., Lai C.J. Growth-restricted dengue virus mutants containing deletions in the 5' noncoding region of the RNA genome. Virology 1995, 207:68-76.
9. Chambers T.J., Hahn C.S., Galler R., Rice C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 1990, 44:649-688.
10. Filomatori C.V., Lodeiro M.F., Alvarez D.E., Samsa M.M., Pietrasanta L., Gamarnik A.V. A 5' RNA element promotes dengue virus RNA synthesis on a circular genome. Genes Dev. 2006, 20:2238-2249.
11. Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002, 10(2):100-103.
12. Guesdon F.M., Greatorex J., Rhee S.R., Fisher R., Hunter E., Lever A.M. Sequences in the 5' leader of Mason-Pfizer monkey virus which affect viral particle production and genomic RNA packaging: development of MPMV packaging cell lines. Virology 2001, 288:81-88.
13. Haas J., Park E.C., Seed B. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 1996, 6:315-324.
14. Halstead S.B., Venkateshan C.N., Gentry M.K., Larsen L.K. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J. Immunol. 1984, 132:1529-1532.
15. Hanson M.R., Kohler R.H. GFP imaging: methodology and application to investigate cellular compartmentation in plants. J. Exp. Bot. 2001, 52(356):529-539.
16. Holden K.L., Stein D.A., Pierson T.C., Ahmed A.A., Clyde K., Iversen P.L., Harris E. Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure. Virology 2006, 344:439-452.
17. Jones C.T., Patkar C.G., Kuhn R.J. Construction and applications of yellow fever virus replicons. Virology 2005, 331:247-259.
18. Kinney R.M., Butrapet S., Chang G.J., Tsuchiya K.R., Roehrig J.T., Bhamarapravati N., Gubler D.J. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 1997, 230:300-308.
19. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., Baker T.S., Strauss J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002, 108:717-725.
20. Laukkanen M., Oker-Blom C., Keinanen K. Secretion of green fluorescent protein from recombinant baculovirus-infected insect cells. Biochem. Biophys. Res. Commun. 1996, 226:755-761.
21. Leardkamolkarn V., Sirigulpanit W., Kinney R.M. Characterization of recombinant dengue-2 virus derived from a single nucleotide substitution in the 5' noncoding region. J. Biomed. Biotechnol. 2010, doi:10.1155/2010/934694.
22. Leardkamolkarn V., Sirigulpanit W. Establishment of a stable cell line coexpressing dengue virus-2 and green fluorescent protein for screening of antiviral compounds. J. Biomol. Screen. 2011, 7. doi: 0.1177/1087057111426903.
23. Leitmeyer K.C., Vaughn D.W., Watts D.M., Salas R., Villalobos I., de C., Ramos C., Rico-Hesse R. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 1999, 73:4738-4747.
24. Lindenbach B.D., Rice C.M. Molecular biology of flaviviruses. Adv. Virus Res. 2003, 59:23-61.
25. Lo M.K., Tilgner M., Bernard K.A., Shi P.Y. Functional analysis of mosquito-borne flavivirus conserved sequence elements within 3' untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication. J. Virol. 2003, 77:10004-10014.
26. Lo M.K., Tilgner M., Shi P.Y. Potential high-throughput assay for screening inhibitors of West Nile virus replication. J. Virol. 2003, 77:12901-12906.
27. Lobigs M., Lee E. Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes. J. Virol. 2004, 78:178-186.
28. Mandl C.W. Flavivirus immunization with capsid-deletion mutants: basics, benefits, and barriers. Viral Immunol. 2004, 17(4):461-472.
29. Massé N., Davidson A., Ferron F., Alvarez K., Jacobs M., Romette J.L., Canard B., Guillemot J.C. Dengue virus replicons: production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the elevation of ribavirin's activity. Antiviral Res. 2010, 86:296-305.
30. McGee C.E., Shustov A.V., Tsetsarkin K., Frolov I.V., Mason P.W., Vanlandingham D.L., Higgs S. Infection, dissemination, and transmission of a west nile virus green fluorescent protein infectious clone by culex pipiens quinquefasciatus mosquitoes. Vector-Borne Zoonotic Dis. 2010, 10:267-274.
31. Ng C.Y., Gu F., Phong W.Y., Chen Y.L., Lim S.P., Davidson A., Vasudevan S.G. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Antiviral Res. 2007, 76:222-231.
32. Pang X., Zhang M., Dayton A.I. Development of Dengue virus type 2 replicons capable of prolonged expression in host cells. BMC Microbiol. 2001, 1:18. (Epub 2001 Aug 24).
33. Pierson T.C., Diamond M.S., Ahmed A.A., Valentine L.E., Davis C.W., Samuel M.A., Hanna S.L., Puffer B.A., Doms R.W. An infectious West Nile virus that expresses a GFP reporter gene. Virology 2005, 334:28-40.
34. Puttikhunt C., Kasinrerk W., Srisa-ad S., Duangchinda T., Silakate W., Moonsom S., Sittisombut N., Malasit P. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization. J. Virol Methods 2003, 109:55-61.
35. Rossi S.L., Zhao Q., O'Donnell V.K., Mason P.W. Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action. Virology 2005, 331:457-470.
36. Rothman A.L., Ennis F.A. Immunopathogenesis of dengue hemorrhagic fever. Virology 1999, 257:1-6.
37. Shi P.Y., Tilgner M., Lo M.K. Construction and characterization of subgenomic replicons of New York strain of West Nile virus. Virology 2002, 296:219-233.
38. Sirigulpanit W., Kinney R.M., Leardkamolkarn V. Substitution or deletion mutations between nt 54 and 70 in the 5' non-coding region of dengue type 2 virus produce variable effects on virus viability. J. Gen. Virol. 2007, 88:1748-1752.
39. Stocks C.E., Lobigs M. Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinantsin C, the signal peptide, and prM. J. Virol. 1998, 72:2141-2194.
40. Tanudji M., Hevi S., Chuck S.L. Improperly folded green fluorescent protein is secreted via a non-classical pathway. J Cell Sci. 2002, 115:3849-3857. The Company of Biologists Ltd., doi:10.1242/jcs.00047.
41. Thomas J.D., Daniel R.A., Errington J., Robinson C. Export of active green fluorescent protein to the periplasm by the twin-arginine translocase (Tat) pathway in Escherichia coli. Mol. Microbiol. 2001, 39:47-53.
42. You S., Falgout B., Markoff L., Padmanabhan R. In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 5'- and 3'-terminal regions that influence RNA structure. J. Biol. Chem. 2001, 276:15581-15591.
43. You S., Padmanabhan R. A novel in vitro replication system for Dengue virus. Initiation of RNA synthesis at the 3'-end of exogenous viral RNA templates requires 5'- and 3'-terminal complementary sequence motifs of the viral RNA. J. Biol. Chem. 1999, 274:33714-33722.
44. Varnavski A.N., Young P.R., Khromykh A.A. Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors. J. Virol. 2000, 74:4394-4403.
45. Zhu W., Qin C., Chen S., Jiang T., Yu M., Yu X., Qin E. Attenuated dengue 2 viruses with deletions in capsid protein derived from an infectious full-length cDNA clone. Virus Res. 2007, 126:226-232.